Mathieu Boudreau
Vice President, Business Development.
pharmaceutical
Foresee Pharmaceuticals
Taiwan
Biography
Dr. Boudreau brings extensive leadership experience in biotechnology and specialty pharmaceuticals companies. Most recently he was Vice President, Corporate Development & Licensing and member of the Executive Committee at Telesta Therapeutics, where he led several strategic transactions, including a significant license agreement for its Phase 3 uro-oncology program with global specialty pharmaceutical company, Ipsen. Dr. Boudreau has amassed broad corporate business development experience that covers the entire transaction lifecycle. He has successfully led and played key roles in both early and late stage/commercial product in-licensing/out-licensing, mergers and acquisitions, corporate strategy, venture creation and operations. Prior to Telesta, Dr. Boudreau was Director, Search & Evaluation - Business Development at Pendopharm, Director, Business Development & Strategic Planning at Pharmascience Inc., and Director, Business Development at Aegera Therapeutics Inc., which was acquired by Pharmascience Inc. in 2011. Dr. Boudreau started his career in business development as co-founder of a diagnostics company. He holds a Ph.D. in Neuroscience from McGill University and a B.Sc. in Biochemistry from the University of Montreal.
Research Interest
pharmaceutical science